How hepatitis E tricks the immune system
Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are… read more.
Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are… read more.
COVID-19 mRNA vaccines are safe to use in pregnancy and pregnant women experienced lower rates of health events post vaccination than similarly aged, non-pregnant vaccinated people, suggests a… read more.
A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for… read more.
Throughout the pandemic the University of Huddersfield’s Department of Pharmacy has been raising awareness on what vaccines are, how they are formulated, and why they’re an important part of… read more.
Peer-reviewed/ Case study/ People An analysis of seven cases of monkeypox that occurred in the UK between 2018-2021 reports on the first instances of in-hospital transmission and household… read more.
A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that two common herpesviruses may contribute to impaired glucose metabolism and… read more.
It is ‘too early’ to consider using a fourth dose of mRNA COVID-19 vaccines in the general population, according to the European Medicines Agency (EMA) and the European… read more.
The National Institute of Mental Health has renewed its support for UCLA’s collaborative Center for HIV Identification, Prevention and Treatment Services, or CHIPTS, with a five-year, $7.5 million grant. The… read more.
Syringe services programs — sites where people who use drugs can access sterile syringes and dispose of injection equipment — often face political backlash. But a new study… read more.
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping… read more.
ViiV Healthcare presented positive interim data from the Phase III CARISEL study of Vocabria + Rekambys (cabotegravir + rilpivirine), which was initiated and conducted during the COVID-19 pandemic…. read more.
The threat of antimicrobial resistance (AMR), whereby antibiotics not longer work well on bacterial illness, is a slow-burning pandemic with the potential to eclipse even the worst of… read more.